Curious what others may like in the recent Market…
I don’t think you can go far wrong in buying NVS, ABT, and PFE at the current prices—or any Big Pharma for that matter (#msg-65895222).
PKI is a solid, half-biotech company that’s been unduly punished in the current market sell-off and is a strong beneficiary of The Global Demographic Tailwind (#msg-65917215).
XOM had two recent bullish insider transactions, including one sizable exercise-and-hold (#msg-66340138).
VALE and CLF have dirt-cheap valuations that discount a monumental collapse in global demand for iron ore, which neither company considers at all likely (#msg-66014159).
In addition to the names mentioned above, I added to AGN APD HNZ MNTA MON PG and PCL during the recent sell-off (#msg-65961928). These aren’t necessarily better buys than the other names in the My Stocks list in my iHub profile, but sector weightings played a role in picking the names above rather than the others.
Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.